thiazoles has been researched along with deferitrin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergeron, RJ; Brittenham, GM; McCosar, BH; McManis, JS; Smith, RE; Weimar, WR; Wiegand, J | 1 |
| Economides, C; Eracleous, E; Kolnagou, A; Kontoghiorghes, GJ | 1 |
| Bree, M; Dagher, R; Donovan, JM; Marquis, J; Plone, M | 1 |
| Kontoghiorghes, GJ | 2 |
| Bergeron, RJ; Bharti, N; McManis, JS; Rocca, JR; Vinson, JR; Wiegand, J; Yao, H | 1 |
| Barton, JC | 2 |
4 review(s) available for thiazoles and deferitrin
| Article | Year |
|---|---|
Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations.
Topics: Benzoates; Carboxylic Acids; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemochromatosis; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Siderophores; Thalassemia; Thiazoles; Triazoles | 2005 |
Preclinical and clinical development of deferitrin, a novel, orally available iron chelator.
Topics: Administration, Oral; Animals; beta-Thalassemia; Carboxylic Acids; Chelation Therapy; Clinical Trials, Phase I as Topic; Dogs; Drug Evaluation, Preclinical; Feces; Humans; Iron; Iron Chelating Agents; Iron Overload; Macaca fascicularis; Molecular Structure; Rats; Thiazoles | 2005 |
Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.
Topics: Benzoates; Carboxylic Acids; Chelation Therapy; Clinical Trials as Topic; Deferasirox; Deferiprone; Deferoxamine; Drug Evaluation; Drug Therapy, Combination; Forecasting; Hemochromatosis; Humans; Hydroxyethyl Starch Derivatives; Iron Chelating Agents; Iron Overload; Molecular Structure; Pyridones; Starch; Thalassemia; Thiazoles; Transfusion Reaction; Triazoles | 2006 |
Drug evaluation: deferitrin (GT-56-252; NaHBED) for iron overload disorders.
Topics: Animals; Carboxylic Acids; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Evaluation, Preclinical; Humans; Iron Chelating Agents; Iron Overload; Structure-Activity Relationship; Thiazoles | 2007 |
4 other study(ies) available for thiazoles and deferitrin
| Article | Year |
|---|---|
Effects of C-4 stereochemistry and C-4' hydroxylation on the iron clearing efficiency and toxicity of desferrithiocin analogues.
Topics: Animals; Bile; Carboxylic Acids; Cebus; Hydroxylation; Iron; Iron Chelating Agents; Ligands; Male; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 1999 |
New chelation therapies and emerging chelating drugs for the treatment of iron overload.
Topics: beta-Thalassemia; Carboxylic Acids; Clinical Trials as Topic; Deferiprone; Deferoxamine; Drug Design; Drug Therapy, Combination; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Thiazoles; Transfusion Reaction | 2006 |
(S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicity.
Topics: Acids; Animals; Carboxylic Acids; Chelating Agents; Drug Design; Ethers; Haplorhini; Iron; Kidney; Male; Molecular Structure; Rats; Structure-Activity Relationship; Thiazoles | 2006 |
Drug evaluation: Deferitrin for iron overload disorders.
Topics: Animals; Carboxylic Acids; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Iron Chelating Agents; Iron Overload; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2007 |